About Conference

Conferences series summons the world's leading diabeticians, endocrinologists, surgeons, physicians, scientists and scholars to the “33rd International Diabetes and Healthcare conference”  on September 09-10, 2024 Paris, France. This leading conference inspires the recent improvements related to diabetes, the main aim of this conference is sharing the knowledge of expertise in the respective field to the upcoming scholars and researchers to increase their knowledge related to diabetes, obesity and endocrinology. The scientific sessions include the various sessions which highlight the Diabetes types and complications, Endocrinology and metabolic syndrome, diabetic retinopathy, diabetic neuropathy, diabetic diet and nutrition, diabetes and heart disease, diabetes tests and diagnosis and prevention and treatment of diabetes.

ME Conferences welcome the delegates across the country to enlighten the young and fresh minds of the scholars, researchers, student communities and industrial delegates to attend the “Diabetes 2024’’ with a theme “Acquainting New Insights of Diabetes & Healthcare” .

Why to attend?

This gathering will exhibit the concentrated learning on the appropriation of knowledge, opportunities to network and talk about science and medicine on diabetes and health care and the recent advances and innovations related to diabetes for the making of better health. New generation scholars and researchers will have the opportunity to explore more areas of expertise on health in diabetes. With members from all around the globe increasing the knowledge about diabetes and health care and the new advance related to diabetes. This is your best opportunity to reach the largest gathering of participants from diabetes community.

Target Audiences:

• Diabetologists

• Researchers

• Endocrinologists

• Doctors

• Physicians

• Nutritionists

• Scientists

• Academic Professionals

• Medical Colleges and Pharma Companies

• Medical Hospitals

• Students

• Business Entrepreneurs

• Manufacture Medical Devices & Companies

• Healthcare Training Institute

• Oncologists

• Neurologists

• Pediatric doctors

• Fitness Professionals

• Public Health Professionals

Why to Attend

Diabetes 2024 offers an opportunity to network with researchers, and as a result, it takes pleasure in providing attendees with a first-look at cutting-edge methodologies, approaches, and the most recent developments in the field of diabetes. The usual sessions to be examined in this diabetes meeting include recent developments in endocrinology and assimilation, diabetes genetic characteristics, clinical diabetes, diabetic problems, diabetes prescriptions and pharmacology, and cell treatment for diabetes. One of the illnesses that are on the rise and getting really serious these days is diabetes. In order to be innovative, the social gathering will be based on the most recent and exciting developments in each component of Diabetes gatherings. We are considering providing a fantastic open portal for all researchers to gather, organise, and manage fresh real movements.

Scope

New insulin analogues, new technology, and diabetes-related equipment will all be covered at the Diabetes 2024, along with the most recent advancements in diabetes research, diagnosis, and prevention.

The Editors will focus on studies that include carefully chosen findings that establish a connection between basic research and translation to disorders connected to diabetes. The editors support the dissemination of original answers to difficult scientific and translational problems connected to research on diabetes and illnesses that are related to metabolism or genetics.

It is expected that authors of JDRT articles will come from a variety of scientific fields with a focus on diabetes as well as various experts who study glucose metabolic homeostasis and related topics. These research would most likely concentrate on risk factors for disease and the pathophysiology of conditions linked to disorders of glucose metabolic dysregulation.

List of Diabetes Universities Worldwide

• Monash University Malaysia
• International Medical University
• Asia Pacific University of Technology and Innovation
• Albert Einstein-Mount Sinai Diabetes Center
• Columbia University
• Indiana Diabetes Research Center 
• Joslin Diabetes Center-Harvard Medical School
• Stanford Diabetes Research Center
• The University of Chicago Diabetes Research 
• Washington University at St. Louis
• Kaiser Foundation Research Institute, California San Francisco
• University of Cambridge
• Johns Hopkins University
• Yale University
• University of California, Los Angeles (UCLA)
• Imperial College London
• University of Melbourne
• Karolinska Institute

Diabetic drugs:

The 50+ diabetes drugs are available in the world in the form of tablets or injection suspension and placed into different drug classes.

• Insulin
• Biguanides / Metformin
• Sulphonylureas
• Meglitinides / Prandial glucose regulator / Glinides
• Alpha-glucosidase inhibitors
• Thiazolidinedione / Glitazones
• DPP-4 inhibitors / Gliptins
• Incretin mimetics / GLP-1 analogues
• Amylin analogues

Sessions/Tracks

Track 1: Types of Diabetes and Their Complications

Diabetes type 1: This condition is typically brought on by an autoimmune reaction in which the body's defence mechanism targets the cells that make insulin. This is due in large part to an unidentified primary cause. Insulin production is extremely low in people with type 1 diabetes. This type of diabetes necessitates daily insulin injections to maintain blood glucose levels under control.

At least 90% of instances of diabetes are type 2 (also known as adult-onset non-insulin type diabetes). Relative insulin resistance and insulin insufficiency, which may already be present by the time diabetes is diagnosed, are its defining characteristics. This form of diabetes can initially be controlled by diet and exercise for the patient.

• Body's defence mechanism
• Insulin insufficiency
• Type 1 diabetes

Track 2: Diabetes Challenges and Control

The balance of carbohydrate metabolism is the major objective of controlling diabetes and its consequences. Patients with insulin resistance are treated with appropriate exercise and food, while those with insulin shortage are treated with insulin pumps or injections. It is necessary to manage or avoid the additional disease-related consequence. The best method to live a healthy life is to maintain a nutritious diet.

• Insulin pumps or injections
• Nutritious diet
• Carbohydrate metabolism

Track 3: Skin diseases caused by Diabetes

Diabetes can have an impact on the skin in addition to other body components. This can sometimes help identify diabetics early. The majority of skin diseases are simply treatable. Only those with diabetes are more likely to experience other skin issues such necrobiosis lipoidica, diabetic dermopathy, diabeticorum, eruptive xanthomatosis, and diabetic blisters.

• Diabetes 
• Skin diseases
• Eruptive xanthomatosis

Track 4: Diabetes Ophthalmology

Blood vessels in the retina's tissue are harmed in diabetic retinopathy. One of the risk factors is poor blood sugar regulation. Blood vessels may enlarge, leak fluid, and aberrant blood vessel growth is seen on the retina's surface. Scar tissue that is present may shrink and separate from the retina. Early signs include blurring, floaters, black spots in the field of vision, and trouble seeing colours. Although diabetic retinopathy cannot be cured, it can be managed with laser treatments and a surgical procedure called a vitrectomy to remove the vitreous gel.

• Retina's tissue
• Diabetic retinopathy
• Vitrectomy 

Track 5: Diabetic Nephropathy

Diabetes causes a disease or damage to your kidneys called diabetic nephropathy, which in extreme cases can result in kidney failure. Our kidneys' minuscule blood channels filter waste items from our blood, which can be destroyed by high blood sugar levels. Weight gain and ankle oedema result from the body retaining too much salt and fluids. Later on, this results in renal disease or failure. Regular urine tests are required to check for kidney impairment because there are no symptoms in the early stages.

• Human kidney
• Blood sugar levels
• Kidney impairment

Track 6: Diabetes Biomarkers

A gene, molecule, or innate characteristic that aids in diagnosing disease is known as a molecular biomarker. HbA1c is regarded as a biomarker for diabetes that can be used to detect retinopathy, vascular disease, and nephropathy risk factors. These serve as prophylactic actions while the condition is subclinical. A quicker and more thorough understanding of the pathological process of diabetes can be achieved with the right use of the biomarker in the development of anti-diabetic medications.

• Molecular biomarker
• Retinopathy
• Nephropathy risk factors

Track 7: Weight Management and Diet

In order to lower the risk of diabetes complications, diabetic individuals must maintain a proper diet. The key is appropriate exercise and healthy eating practises. In general, a low-carb diet is necessary since whole grains, vegetables, fruits, and nuts are macronutrients that raise blood sugar. Low-fat foods are the best source, and a diet high in fibre is favoured. The My Plate method, glycaemic index, carb tracking, and TLC diet are a few techniques for a healthy diet.

• Diabetes complications
• Low-carb diet
• Glycaemic index

Track 8: Thyroid Disorders

The thyroid is a butterfly-shaped gland that is situated near the base of the Adam's apple neck. It is a component of the endocrine system, which controls a variety of bodily functions. The thyroid glands create androgen prohormones that control the metabolism of the body. Hypothyroidism results from the thyroid producing less hormone, and hyperthyroidism results from the thyroid producing too much hormone. More women than males experience thyroid disorders.

• Endocrine system
• Thyroid gland
• Hyperthyroidism 

Track 9: Gestational Diabetes

The initial analysis of gestational diabetes occurs during pregnancy. Similar to type 1 and type 2 diabetes, gestational diabetes results in noticeably elevated glucose levels. When you eat, the majority of the food is broken down into a sugar called glucose by your stomach-related system. It is the cause of the mother's blood sugar (glucose level) rising excessively high during pregnancy. When your body is unable to produce enough of the hormone insulin while you are pregnant, gestational diabetes develops.

• Gestational diabetes
• Glucose level
• Insulin 

Track 10: Stem Cell Therapy for Diabetes

The treatment of patients with diabetes mellitus may greatly benefit from the use of undifferentiated or undeveloped cells. The developmental stages and transcription factors involved in this process have been defined by research on the capacity of human embryonic undifferentiated cells to segregate into islet cells. In any event, ethical considerations as well as the possibility for teratoma formation limit the clinical applications of human embryonic stem cells.

• Umbilical cord stem cells
• Diabetes type 2
• Bone marrow

Track 11: Diabetes Tests and Diagnosis

The fasting plasma glucose (FPG) test is a blood test that examines blood glucose levels in just a few seconds. For the best reliable results, do this test first thing in the morning after fasting for at least 8 hours. The A1C test is used to determine the average blood glucose levels during the past three months. Food and water can be consumed before the A1C test, and other factors like as age, anaemia, or any other blood problem will be taken into account when the A1C test is used to diagnose diabetes. The results of an A1C test are expressed as a percentage, such as A1C of 7%. The following approaches are used to diagnose diabetes.

• Losing weight
• Eating well
• Exercising regularly

Track 12: Diabetes and Heart Disease

The connection between diabetes and heart disease starts with high blood sugar levels, the high glucose in the blood can damage the arteries, which causes them to become stiff and hard. Atherosclerosis is a condition which occurs when blood vessels are filled with fatty material. This might eventually block the blood flow to heart or brain, which causes the heart attack or heart stroke.

High blood glucose from diabetes can damage blood vessels and nerves which control heart and blood vessels. The factors affecting the chances of developing heart disease or heart stroke are

• Smoking
• Abnormal cholesterol  levels
• Obesity and belly fat

Track 13: Herbal and Alternative Remedies

Herbal therapies have led to improved glucose control in many people with diabetes, using the more natural ingredients can lead to manage the blood sugar level. Plant based therapies like

• Ginger
• Okra
• Bitter melon

Track 14: Diabetic Drug Market

The global diabetic drugs market is divided on the basis of drug type, application and geography. The drug types advised such as Injectable Drugs and Oral Drugs.  Injectable drugs are the drugs which are injected directly into the body such as Insulin, Exenatide, Liragultide, Pramlintide. The Oral medications work by different mechanisms like producing more insulin and decreasing the insulin resistance of the body and by reducing gluconeogenesis of the liver.  The oral medications available in the drug market such as

• Thiazolidinediones
• DPP-4 Inhibitors
• Alpha-glucosidase Inhibitors

Track 15: Advanced Therapies and Diagnostic Methods

The therapeutics of type 1 diabetes includes stimulation of insulin secretion through GLP analogues like insulin injections to compensate for beta cell defects, DPP-4 inhibition by Sitagliptin, and increased islet survival and islet cell regeneration. The therapeutics of type 2 includes several conventional therapies like sulfonylureas, Repaglinide enhance insulin secretion and Troglitazone. By keeping the blood sugar level as close to normal as possible can delay or prevent diabetes.  Treatment for diabetes includes.

These are commonly used in ayurvedic medicine and oriental medicine for treating diabetes. Certain herbs, vitamins, and supplements may relate with diabetes medications including insulin and increase the hypoglycemic effects. Herbs and plant sources listed below have been employed traditionally in the treatment of diabetes.

• Ficus Carica Ginseng
• Berberine
• Cinnamomym Tamala

Participation Options and Benefits

Diabetic studies, provides the participants with different modes or ways to participate  as Delegate or Speaker under either ACADEMIC / STUDENT / BUSINESS Category. 

• Keynote speaker: 45-50 minutes
• Speaker (oral presentation): 25-30 minutes (only one person can present)
• Speaker (workshop): 45-50 minutes (more than 1 can present)
• Speaker (special session): 45-50 minutes (more than 1 can present)
• Speaker (symposium): more than 45 minutes (more than 1 can present)
• Delegate(only registration): will have access to all the sessions with all the benefits of registration
• Poster presenter:  can present a poster and enjoy the benefits of delegate
• Remote attendance:  can participate via video presentation or e-poster presentation
• Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes
• Media partner
• Sponsor
• Collaborator

PARTICIPATION BENEFITS:

• Attend Keynote Presentation by world’s most eminent researchers
• Access to all the sessions
• Get worldwide acknowledgment to your profile and Research
• Get your abstracts published with unique DOI in International Journals
• Get up to 50% discounts for publishing your entire article in our open access International Journals
• Get Handbooks and conference kits
• Get an access to the network with eminent personalities from worldwide
• To learn and expand the knowledge from Top immunologists, Professionals
• Get your Abstract published and Certified for your participation
• Mark new links and trigger  your profession
• Acquire a global exposure to your research idea

Market Analysis

The 33nd International Conference on Diabetes and Healthcare Conference scheduled to be held on September 09-10, 2024, in Paris, France, presents a significant market opportunity within the field of diabetes research, medication, and treatment.

The global market for diabetes and related products and services has been experiencing substantial growth in recent years. The rising prevalence of diabetes, coupled with increased awareness and advancements in medical technology, has fueled the demand for innovative solutions and effective treatment modalities.

The conference provides a platform for researchers, healthcare professionals, and industry experts to showcase the latest scientific advancements, clinical trials, and emerging technologies in the field of diabetes. This offers an excellent opportunity for participants to explore cutting-edge products, therapies, and diagnostic tools presented by leading companies and research organizations.

The conference also serves as a hub for networking and collaboration, allowing attendees to forge strategic partnerships and explore potential business opportunities. Pharmaceutical companies, medical device manufacturers, biotechnology firms, and healthcare service providers can benefit from exposure to a highly targeted audience of key opinion leaders, clinicians, and researchers in the diabetes field.

Furthermore, the conference facilitates knowledge exchange and professional development through keynote lectures, panel discussions, and interactive sessions. It offers a platform for participants to enhance their understanding of current trends, challenges, and best practices in clinical diabetes management, medication, and treatment.

With its location in the vibrant city of Paris, the conference is poised to attract a diverse and international audience. The city's rich cultural heritage, world-class healthcare infrastructure, and renowned research institutions further contribute to the overall appeal and market potential of the event.

In conclusion, the 32nd International Conference on Clinical Diabetes, Diabetic Medication & Treatment presents a significant market opportunity for stakeholders in the diabetes research, medication, and treatment industry. It offers a unique platform for knowledge exchange, networking, and business development, fostering innovation and advancements in the field of diabetes care.